Showing results 11 - 20 of 20
We are pleased to be recognised in the 2023 Chambers and Partners guide. Chambers and Partners identifies the best law firms globally through interviews and client feedback. The directory assess...
The development of drugs can be a slow process due to the need for safety and extensive testing. Before a drug can proceed to human trials, it is important to ascertain information relating to efficac...
For a fourth consecutive year, GJE has been top-ranked on the Financial Times’ leader board of best firms in “Europe’s Leading Patent Law Firms 2022” annual awards. The firm received five Gold...
We are delighted to announce that Ross Cummings and Ian Jones have joined the Partnership. Ross Cummings joined GJE in 2017, having previously worked at another top tier firm of patent and trade mark ...
GJE has been listed joint first place with two other firms on the Financial Times leader board of top firms in the “Europe’s Leading Patent Law Firms 2021” annual awards. The firm received...
Tuesday 22nd of June, 2021, 2:00pm (London UK – BST) 60 mins What will the talk cover? Inventions dependent on chemistry span many different technology areas – from coatings and polymers...
Tuesday 15th December 2020, 2:00pm (London UK – BST) 45mins What will the talk cover? Gill Jennings & Every has one of the most experienced and active patent opposition practices in Europe, ...
GJE has been listed joint first place on the Financial Times leader board of top firms in the “Europe’s Leading Patent Law Firms 2020” annual awards. The firm received five Gold award...
We are delighted to announce that three partners have been recognised in the 2020 edition of Who’s Who Legal. Who’s Who Legal identifies the foremost legal practitioners and consulting exper...
We are delighted to have been recognised as a leading European IP firm by the Financial Times. In addition, we have received five Gold Awards for our work in the following industry sectors:...